# Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)

> **NCT01507545** · PHASE2 · TERMINATED · sponsor: **Morphotek** · enrollment: 154 (actual)

## Conditions studied

- Metastatic Colorectal Cancer
- Colorectal Cancer

## Interventions

- **DRUG:** MORAb-004
- **DRUG:** Placebo
- **OTHER:** Best supportive care

## Key facts

- **NCT ID:** NCT01507545
- **Lead sponsor:** Morphotek
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-03-27
- **Primary completion:** 2013-10-20
- **Final completion:** 2013-10-20
- **Target enrollment:** 154 (ACTUAL)
- **Why stopped:** By the sponsor at the end of Stage 1 due to futility.
- **Last updated:** 2022-05-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01507545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01507545, "Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01507545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*